Over the last few decades, significant improvement in outcomes has been observed for
myeloma patients, mainly as a result of the use of currently available approved antimyeloma …

Survival of myeloma patients has greatly improved with the use of autologous stem cell
transplantation and novel agents, such as proteasome inhibitors, immunomodulatory drugs …

In contrast to the upfront setting in which the role of high-dose therapy with autologous
hematopoietic cell transplantation (HCT) as consolidation of a first remission in patients with …

The treatment of multiple myeloma has undergone significant changes and has resulted in
the achievement of molecular remissions, the prolongation of remission duration, and …

Abstract The DiseaseConnect (http://disease-connect. org) is a web server for analysis and
visualization of a comprehensive knowledge on mechanism-based disease connectivity …

Despite remarkable progress in survival with the availability of novel agents, an
overwhelming majority of patients with multiple myeloma (MM) relapse and the curability of …

We describe the use and outcomes of allogeneic hematopoietic stem cell transplantation
(allo-HSCT) for multiple myeloma (MM) in Europe between January 1990 and December …

Zerumbone derived from a subtropical ginger, Zingiber zerumbet Smith, was previously
reported to have antitumor growth and anti-inflammatory properties in some types of cancer …

Cellular therapies are a rapidly evolving approach to myeloma treatment, which bring a
unique mechanism of action with the potential to overcome drug resistance and induce long …

Background Despite recent advances, multiple myeloma (MM) remains incurable. However,
the appearance of allogeneic stem cell transplantation (allo-SCT) through graft-versus …